Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study

• OGURA Michinori

  Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital

• MORISHIMA Yasuo

  Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital

• KOBAYASHI Yukio

  Hematology Division, National Cancer Center Hospital

• UIKE Naokuni

  Department of Hematology, National Kyushu Cancer Center Hospital

• SUGAI Susumu

  Department of Hematology and Immunology, Kanazawa Medical University

• CHOU Takaaki

  Department of Hematology, Niigata Cancer Center Hospital

• KASAI Masaharu

  Department of Hematology, Sapporo Hokuyu Hospital

• MIURA Ikuo

  Third Department of Internal Medicine, Akita University School of Medicine

• MURAYAMA Tohru

  Department of Hematology, Hyogo Medical Center for Adults

• MATSUNO Yoshihiro

  Clinical Laboratory Division, National Cancer Center Hospital

• NAKAMURA Shigeo

  Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital

• MORI Shigeo

  Department of Pathology, Institute of Medical Science, University of Tokyo

• OHASHI Yasuo

  Biostatistics Sciences, School of Health Science and Nursing Biostatistics, University of Tokyo

• TOBINAI Kensei

  Hematology Division, National Cancer Center Hospital

• Members of the Cladribine Study Group

収録刊行物

• International journal of hematology

  International journal of hematology 80 (3), 267-277, 2004-10-15

キーワード

• Cladribine
• 2-CdA
• Indolent lymphoma
• Phase II study
• Prolonged cytopenia
• Secondary MDS

詳細情報

• CRID: 1570572700127447552
• NII論文ID: 10013720159
• NII書誌ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2006087220
• 本文言語コード: en
• データソース種別:
  • CiNii Articles